Unilateral 6-hydroxydopamine lesion mouse model of Parkinson’s disease

Output Details

To generate a mouse model of Parkinson's disease, unilateral injection of 6-OHDA(6-hydroxydopamine) into the medial forebrain bundle (MFB) was performed. Three to four weeks later, a drug-free cylinder test was used to assess the extent of lesion.
Tags
  • 6-OHDA
  • Animal
  • Animal models
  • In Vivo
  • Mouse
  • Parkinson's disease

Meet the Authors

  • User avatar fallback logo

    Cristina Alcacer,

  • User avatar fallback logo

    Shenyu Zhai, PhD

    Key Personnel: Team Surmeier

    Northwestern University

Aligning Science Across Parkinson's
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.